Literature DB >> 7093122

DNA content of human kidney carcinoma cells in relation to histological grading.

H Baisch, U Otto, K König, G Klöppel, M Köllermann, W A Linden.   

Abstract

Ploidy and cell-cycle stage were determined by flow cytometry (FCM) in 46 human renal carcinomas. Cell populations with aneuploid DNA were detected in 46% of these. In the investigated samples, the fraction of cells with abnormal DNA content varied from 8 to 100%. The proliferative activity was generally low as indicated by the small fractions of cells in S and (G2 + M) phases. This was confirmed by the labelling indices on autoradiographic slides. The fraction of cells in phases S and (G2 + M) for tumours that were pre-irradiated with 15 or 25 Gy before nephrectomy was only slightly less than in unirradiated tumours. Comparison of the FCM ploidy with the results of histological grading showed that all cases classified as the most malignant grades IV or IIIB (according to the nuclear and to the combined grading system of Syrjänen and Hjelt (1978) were hyperdiploid. On the other hand, 45% of the hyperdiploid and 89% of the diploid tumours were of the low grades I and II. After a follow-up for 6 months to 2 years, 8/17 patients with hyperdiploid and only 1/14 patients with diploid tumours have died or relapsed with multiple metastases. The results indicate that the aneuploidy of tumours, measured by FCM, might provide useful additional information for prognosis.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7093122      PMCID: PMC2011044          DOI: 10.1038/bjc.1982.140

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  9 in total

1.  Flow microfluorometry and transrectal fine-needle biopsy in the classification of human prostatic carcinoma.

Authors:  P Bichel; P Frederiksen; T Kjaer; P Thommesen; L L Vindelov
Journal:  Cancer       Date:  1977-09       Impact factor: 6.860

2.  Determination of ploidy and proliferative characteristics of human solid tumors by pulse cytophotometry.

Authors:  B Barlogie; W Göhde; D A Johnston; L Smallwood; J Schumann; B Drewinko; E J Freireich
Journal:  Cancer Res       Date:  1978-10       Impact factor: 12.701

3.  Cellular DNA content as a marker of neoplasia in man.

Authors:  B Barlogie; B Drewinko; J Schumann; W Göhde; G Dosik; J Latreille; D A Johnston; E J Freireich
Journal:  Am J Med       Date:  1980-08       Impact factor: 4.965

4.  In vitro labeling and gold activation autoradiography for determination of labeling index and DNA synthesis times of solid tumors.

Authors:  P G Braunschweiger; L Poulakos; L M Schiffer
Journal:  Cancer Res       Date:  1976-05       Impact factor: 12.701

5.  Evaluation of flow cytometric data of human tumours. Correction procedures for background and cell aggregations.

Authors:  H P Beck
Journal:  Cell Tissue Kinet       Date:  1980-03

6.  Modal DNA content of human intracranial neoplasms studied by flow cytometry.

Authors:  S J Mørk; O D Laerum
Journal:  J Neurosurg       Date:  1980-08       Impact factor: 5.115

7.  Grading of human renal adenocarcinoma.

Authors:  K Syrjänen; L Hjelt
Journal:  Scand J Urol Nephrol       Date:  1978

8.  Relationship between the pretreatment proliferative activity of marrow blast cells and prognosis of acute lymphoblastic leukaemia of childhood.

Authors:  J H Scarffe; I M Hann; D I Evans; P Morris Jones; M K Palmer; J S Lilleyman; D Crowther
Journal:  Br J Cancer       Date:  1980-05       Impact factor: 7.640

9.  Prognostic significance of modal DNA value and other factors in malignant tumours, based on 1465 cases.

Authors:  N B Atkin; R Kay
Journal:  Br J Cancer       Date:  1979-08       Impact factor: 7.640

  9 in total
  5 in total

1.  Acridine orange flow cytometric analysis of renal cell carcinoma. Clinicopathologic implications of RNA content.

Authors:  A K el-Naggar; J G Batsakis; K Teague; G Giacco; V F Guinee; D Swanson
Journal:  Am J Pathol       Date:  1990-08       Impact factor: 4.307

Review 2.  Clinical and biological significance of aneuploidy in human tumours.

Authors:  M L Friedlander; D W Hedley; I W Taylor
Journal:  J Clin Pathol       Date:  1984-09       Impact factor: 3.411

3.  Flow-cytophotometric studies in renal carcinoma.

Authors:  H W Schwabe; H D Adolphs; J Vogel
Journal:  Urol Res       Date:  1983

4.  A non-diploid DNA status is linked to poor prognosis in renal cell cancer.

Authors:  Franziska Büscheck; Christoph Fraune; Martina Kluth; Maximilian Lennartz; Ronald Simon; Claudia Hube-Magg; Christian Morlock; Silvano Barbieri; Carolin Wahl; Christian Eichelberg; Christina Möller-Koop; Doris Höflmayer; Corinna Wittmer; Waldemar Wilczak; Guido Sauter; Margit Fisch; Till Eichenauer; Michael Rink
Journal:  World J Urol       Date:  2020-05-02       Impact factor: 4.226

5.  DNA index of ovarian carcinomas from 56 patients: in vivo in vitro studies.

Authors:  E Erba; M Vaghi; S Pepe; G Amato; M Bistolfi; P Ubezio; C Mangioni; F Landoni; L Morasca
Journal:  Br J Cancer       Date:  1985-10       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.